A Comparative Analysis of Long-Term Survival of Robotic Versus Thoracoscopic Lobectomy

Sesti, Joanna; Langan, Russell C.; Bell, Jaimie; Nguyen, Andrew; Turner, Amber L.; Hilden, Patrick; Leshchuk, Kalyna; Dabrowski, Michael; Paul, Subroto

doi:10.1016/j.athoracsur.2020.03.085

Cited by 34 publications

(26 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Five-year disease recurrence has reported to be from 3% to 24.9% depending on cancer stage, which is also comparable to open surgery for appropriately matched patients [32,39]. In this series and others, overall and disease-free survival at three and five years did not differ between RATS and either open surgery or VATS [32,37,38,[40][41][42][43]. These results all suggest that robotic lung resection is a non-inferior alternative to prior surgical options.…”

Section: Patient Outcomessupporting

confidence: 62%

Robotic Surgery for Non-Small Cell Lung Cancer

Li¹,

Blasberg²

2021

Lung Cancer - Modern Multidisciplinary Management

View full text Add to dashboard Cite

Pulmonary resection has been a cornerstone in the management of patients with non-small cell lung cancer (NSCLC) for decades. In recent years, the popularity of minimally-invasive techniques as the primary method to manage NSCLC has grown significantly. With smaller incisions and a lower incidence of peri-operative complications, minimally-invasive lung resection, accomplished through keyhole incisions with miniaturized cameras and similarly small instruments that work through surgical ports, has been shown to retain equivalent oncologic outcomes to the traditional gold standard open thoracotomy. This technique allows for the safe performance of anatomic lung resection with complete lymphadenectomy and has been a part of thoracic surgery practice for three decades. Robotic-assisted thoracoscopic surgery (RATS) represents another major advancement for lung resection, broadening the opportunity for patients to undergo minimally invasive surgery for NSCLC, and therefore allowing a greater percentage of the lung cancer population to benefit from many of the advantages previously demonstrated from video assisted thoracoscopic surgery (VATS) techniques. RATS surgery is also associated with several technical advantages to the surgeon. For a surgeon who performs open procedures and is looking to adopt a minimally invasive approach, RATS ergonomics are a natural transition compared to VATS, particularly given the multiple degrees of freedom associated with robotic articulating instruments. As a result, this platform has been adopted as a primary approach in numerous institutions across the United States. In this chapter, we will explore the advantages and disadvantages of robotic-assisted surgery for NSCLC and discuss the implications for increased adoption of minimally invasive surgery in the future of lung cancer treatment.

show abstract

Section: Patient Outcomessupporting

confidence: 62%

Robotic Surgery for Non-Small Cell Lung Cancer

Li¹,

Blasberg²

2021

Lung Cancer - Modern Multidisciplinary Management

View full text Add to dashboard Cite

show abstract

“…Compared with open lobectomy, video-assisted thoracoscopic lobectomy was associated with a lower incidence of arrhythmias, blood transfusion, as well as a shorter length of stay, and chest tube duration. 6 7 8 Robotic-assisted lobectomy has been introduced over the last decade as an alternative approach to thoracoscopic lobectomy. In addition to the thoracoscopic advantages, proponents of the robotic approach argue that it allows for improved lymph node yields with a potential for improved overall survival.…”

Section: Discussionmentioning

confidence: 99%

“…In addition to the thoracoscopic advantages, proponents of the robotic approach argue that it allows for improved lymph node yields with a potential for improved overall survival. 6 8 At our institution, all patients scheduled to undergo lobectomy without obvious chest wall invasion have begun robotically. We subscribe to the theory that robotic lobectomy offers the aforementioned advantages, specifically reduced pain, less blood loss, shorter hospital stays, quicker return to preop functionality, and most importantly higher lymph node yield.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Robotic Resection of Pulmonary Epithelial Myoepithelial Carcinoma: A Case Report

Jindani

Lopez

Miquel

et al. 2021

Thorac Cardiovasc Surg Rep

View full text Add to dashboard Cite

Background Pulmonary epithelial–myoepithelial carcinoma (P-EMC) is an extremely rare, well-differentiated, and malignant neoplasm originating from submucosal bronchial glands in the lung. EMCs arise mainly in the salivary glands. Case Description This case represents an asymptomatic 78-year-old male with a remote 75-pack-year history of smoking who presents with a solitary endobronchial lesion, which is suggestive of a primary lung EMC, detected on annual screening chest computed tomography (CT) scan. Conclusion A recent review of literature reveals less than 50 documented cases of the pulmonary subtype of this tumor worldwide. We are reporting a unique case of robot-assisted pulmonary lobectomy for a P-EMC.

show abstract

“…We performed this analysis to exclude the impact of postoperative complications on the immediate postoperative period during which there impact would be the greatest. Postoperative complications were defined using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD‐9‐CM) codes (Appendix Table 1) as previously described 14,15 . Current procedural terminology codes (CPT) were used along with ICD‐9‐CM codes (Appendix Table 1) to define major anastomotic leak, as done previously 7 .…”

Section: Methodsmentioning

confidence: 99%

Impact of postoperative complications on long‐term survival after esophagectomy in older adults: A SEER‐Medicare analysis

Sesti¹,

Almaz

Bell³

et al. 2021

Journal of Surgical Oncology

Self Cite

View full text Add to dashboard Cite

Background Esophagectomy is a complex procedure associated with a high rate of postoperative complications. It is not clear whether postoperative complications effect long‐term survival. Most studies report the results from single institutions. Methods We examined the Surveillance, Epidemiology and End Results (SEER)‐Medicare database to assess whether long‐term overall and cancer‐specific mortality of patients undergoing esophagectomy for cancer is impacted by postoperative complications. Results Nine hundred and forty patients underwent esophagectomy from 2007 to 2014, of which 50 died, resulting in a cohort of 890 patients. Majority were males (n = 764, 85.8%) with adenocarcinoma of the lower esophagus. Almost 60% of the group had no neoadjuvant therapy. Four hundred and fifty‐five patients had no major complications (51.1%), while 285 (32.0%) and 150 (16.9%) patients had one, two, or more major complications, respectively. Overall survival at 90 days was 93.1%. Multivariate analysis of patients followed up for a minimum of 90 days demonstrated that the number of complications was significantly associated with decreased overall survival but no impact on cancer‐specific survival. Conclusions Our population‐based analysis with its inherent limitations suggests that patients undergoing esophagectomy who experience complications have worse overall survival but not cancer‐specific survival if they survive at least 90 days from the date of surgery.

show abstract

A Comparative Analysis of Long-Term Survival of Robotic Versus Thoracoscopic Lobectomy

Cited by 34 publications

References 22 publications

Robotic Surgery for Non-Small Cell Lung Cancer

Robotic Surgery for Non-Small Cell Lung Cancer

Robotic Resection of Pulmonary Epithelial Myoepithelial Carcinoma: A Case Report

Impact of postoperative complications on long‐term survival after esophagectomy in older adults: A SEER‐Medicare analysis

Contact Info

Product

Resources

About